Breast Cancer

December 25, 2020

Following the 2020 San Antonio Breast Cancer Symposium, Erika P. Hamilton, MD, and William J. Gradishar, MD, shared their key takeaways and insights from the most impactful data presented during this year’s meeting.

December 22, 2020

A new study found that the rate of cancer in adolescents and young adults increased by 29/6% between 1973 and 2015.

November 19, 2020

Merck earned a new indication for pembrolizumab (Keytruda), in combination with chemotherapy, to treat locally recurrent unresectable or metastatic triple-negative breast cancer (TNBC).

November 10, 2020

Study shows implementing the newly cleared software can slightly improve sensitivity and false negatives.

October 27, 2020

From OncLive, five experts share their perspectives and opinions on the latest research related to triple-negative breast cancer.

October 07, 2020

In a recent video from OncLive, Erika P. Hamilton, MD, highlights the initial findings from the ongoing phase 1b/2 LIO-trial in advanced metastatic tumors.

September 22, 2020

According to new research, women with ductal carcinoma in situ (DCIS) are more than three times as likely to suffer from breast cancer mortality than women in the general population.

September 22, 2020

Postmenopausal women are significantly more likely to meet criteria for metabolic syndrome than are premenopausal women, according to a cross-sectional analysis of women aged 45 to 85.

September 16, 2020

Officials from the Food and Drug Administration (FDA) issued a safety alert on Sept. 8 about potential efficacy and safety concerns with Tecentriq in combination with Paclitaxel for breast cancer treatment.

August 18, 2020

Results from the study showed antitumor activity and safety to be similar to olaparib and durvalumab monotherapy outcomes.